The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly Patients
Open accessAbstract
BACKGROUND: Adjuvant chemotherapy is standard treatment for patients with resected colon cancer who are at high risk for recurrence, but the efficacy and toxicity of such treatment in patients more than 70 years of age are controversial. METHODS: We performed a pooled analysis, based on the intention to treat, of individual patient data from seven phase 3 randomized trials (involving 3351 patients) in which the effects of postoperative fluorouracil plus leucovorin (five trials) or fluorouracil plus levamisole (two trials) were compared with the effects of surgery alone in patients with stage II or III colon cancer. The patients were grouped into four age categories of equal size, and analyses were repeated with 10-year age ranges (< or =50, 51 to 60, 61 to 70, and >70 years), with the same conclusions. The toxic effects measured in all trials were nausea or vomiting, diarrhea, stomatitis, and leukopenia. Patients in the fluorouracil-plus-leucovorin and fluorouracil-plus-levamisole groups were combined for the efficacy analysis but kept separate for toxicity analyses. RESULTS: Adjuvant treatment had a significant positive effect on both overall survival and time to tumor recurrence (P<0.001 for each, with hazard ratios of death and recurrence of 0.76 [95 percent confidence interval, 0.68 to 0.85] and 0.68 [95 percent confidence interval, 0.60 to 0.76], respectively). The five-year overall survival was 71 percent for those who received adjuvant therapy, as compared with 64 percent for those untreated. No significant interaction was observed between age and the efficacy of treatment. The incidence of toxic effects was not increased among the elderly (age >70 years), except for leukopenia in one study. CONCLUSIONS: Selected elderly patients with colon cancer can receive the same benefit from fluorouracil-based adjuvant therapy as their younger counterparts, without a significant increase in toxic effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885
Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma
Moertel, C. G., Fleming, T. R., Macdonald, J. S., Haller, D. G., Laurie, J. A., Goodman, P. J., Ungerleider, J. S., Emerson, W. A., Tormey, D. C., Glick, J. H., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002083220602 · Cited by 2,256
Self-citationSystemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
Early Breast Cancer Trialist's Collaborative Group (1992) · The Lancet · doi:10.1016/0140-6736(92)90997-h · Cited by 2,182
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
Hutchins, L. F., Unger, J. M., Crowley, J. J., Coltman, C. A., & Albain, K. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912303412706 · Cited by 2,174
Efficacy of adjuvant fluorouracil and folinic acid in colon cancer
(1995) · The Lancet · doi:10.1016/s0140-6736(95)90696-7 · Cited by 1,066
Dose: A critical factor in cancer chemotherapy
Frei, E., & Canellos, G. P. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90472-6 · Cited by 839
Dose-Response Effect of Adjuvant Chemotherapy in Breast Cancer
Bonadonna, G., & Valagussa, P. (1981) · New England Journal of Medicine · doi:10.1056/nejm198101013040103 · Cited by 774
Laurie, J. A., Moertel, C. G., Fleming, T. R., Wieand, H. S., Leigh, J. E., Rubin, J., McCormack, G. W., Gerstner, J. B., Krook, J. E., & Malliard, J. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.10.1447 · Cited by 700
Patterns of Care Related to Age of Breast Cancer Patients
Greenfield, S. (1987) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1987.03390200106023 · Cited by 546
Mamounas, E., Wieand, S., Wolmark, N., Bear, H. D., Atkins, J. N., Song, K., Jones, J., & Rockette, H. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1349 · Cited by 531
Efficacy of Adjuvant Fluorouracil and Folinic Acid in B2 Colon Cancer
(1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1356 · Cited by 444
O'Connell, M. J., Laurie, J. A., Kahn, M., Fitzgibbons, R. J., Erlichman, C., Shepherd, L., Moertel, C. G., Kocha, W. I., Pazdur, R., Wieand, H. S., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.295 · Cited by 417
Self-citationChoice of Cancer Therapy Varies With Age of Patient
Samet, J. (1986) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1986.03370240055036 · Cited by 403
NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer
(1990) · JAMA · doi:10.1001/jama.264.11.1444 · Cited by 394
Cancer in the elderly: why so badly treated?
Fentiman, I. S., Tirelli, U., Monfardini, S., Schneider, M., Festen, J., Cognetti, F., & Aapro, M. S. (1990) · The Lancet · doi:10.1016/0140-6736(90)91075-l · Cited by 345
Representation of older patients in cancer treatment trials
Trimble, E. L., Cain, D., Ungerleider, R. S., Friedman, M. A., Carter, C. L., & Freidlin, B. (1994) · Cancer · doi:10.1002/1097-0142(19941001)74:7+<2208::aid-cncr2820741737>3.0.co;2-# · Cited by 343
Essentials of Clinical Geriatrics.
(1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-6-934_3 · Cited by 293
Begg, C. B., & Carbone, P. P. (1983) · Cancer · doi:10.1002/1097-0142(19831201)52:11<1986::aid-cncr2820521103>3.0.co;2-7 · Cited by 275
Stein, B. N., Petrelli, N. J., Douglass, H. O., Driscoll, D. L., Arcangeli, G., & Meropol, N. J. (1995) · Cancer · doi:10.1002/1097-0142(19950101)75:1<11::aid-cncr2820750104>3.0.co;2-n · Cited by 271
Adjuvant or Palliative Chemotherapy for Colorectal Cancer in Patients 70 Years or Older
Popescu, R. A., Norman, A., Ross, P. J., Parikh, B., & Cunningham, D. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2412 · Cited by 264
Influence of sex and age on fluorouracil clearance.
Milano, G., Etienne, M. C., Cassuto-Viguier, E., Thyss, A., Santini, J., Frenay, M., Renee, N., Schneider, M., & Demard, F. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.7.1171 · Cited by 260
The National Cancer Data Base report on colon cancer
Jessup, J. M., McGinnis, L. S., Steele, G. D., Menck, H. R., & Winchester, D. P. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960815)78:4<918::aid-cncr32>3.0.co;2-w · Cited by 260
Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer
Francini, G., Petrioli, R., Lorenzini, L., Mancini, S., Armenio, S., Tanzini, G., Marsili, S., Aquino, A., Marzocca, G., Civitelli, S., et al. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90748-x · Cited by 241
Self-citationGelman, R. S., & Taylor, S. G. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.12.1404 · Cited by 203
Christman, K. (1992) · JAMA · doi:10.1001/jama.1992.03490010059030 · Cited by 196
Guthrie, T. H., Porubsky, E. S., Luxenberg, M. N., Shah, K. J., Wurtz, K. L., & Watson, P. R. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.2.342 · Cited by 196
Vestal, R. E. (1997) · Cancer · Cited by 189
Relationship Between Age at Diagnosis and Treatments: Received by Cancer Patients
Mor, V., Masterson‐Allen, S., Goldberg, R. J., Cummings, F. J., Glicksman, A. S., & Fretwell, M. D. (1985) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1985.tb06313.x · Cited by 172
Self-citationCancer chemotherapy in the older patient
Balducci, L., & Extermann, M. (1997) · Cancer · Cited by 147
Christman, K. (1992) · JAMA · doi:10.1001/jama.268.1.57 · Cited by 130
Cooper, G. S., Yuan, Ž., Landefeld, C. S., Johanson, J. F., & Rimtn, A. A. (1995) · Cancer · Cited by 121
Zalcberg, J. R., Kerr, D. J., Seymour, L. W., & Palmer, M. K. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00259-7 · Cited by 115
Mahoney, T. (2000) · Archives of Surgery · doi:10.1001/archsurg.135.2.182 · Cited by 109
Peterson, B. L., & George, S. L. (1993) · Controlled Clinical Trials · doi:10.1016/0197-2456(93)90031-8 · Cited by 99
Chiara, S., Nobile, M. T., Vincenti, M., Lionetto, R., Gozza, A., Barzacchi, M. C., Sanguineti, O., Repetto, L. M., & Rosso, R. (1998) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050826 · Cited by 90
Steinberg, J., Erlichman, C., Gadalla, T., Fine, S., & Wong, A. O. (1992) · European Journal of Cancer · doi:10.1016/0959-8049(92)90011-p · Cited by 64
Furner, S. E., Brody, J. A., & Jankowski, L. M. (1997) · Springer eBooks · doi:10.1007/978-1-4757-2705-0_3 · Cited by 58
Pharmacology and organ toxicity of chemotherapy in older patients.
Balducci, L., & Mowry, K. (1992) · PubMed · Cited by 51
Cascinu, S., Ferro, E. D., & Catalano, G. (1996) · American Journal of Clinical Oncology · doi:10.1097/00000421-199608000-00010 · Cited by 45
Adjuvant Treatment of Colorectal Cancer in the Elderly.
Aschele, C., Guglielmi, A., Tixi, L., Bolli, E., Mori, A., Lionetto, R., Rosso, R., & Sobrero, A. F. (1995) · PubMed · Cited by 14
p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan
Nose, H., Imazeki, F., Ohto, M., & Omata, M. (1993) · Cancer · doi:10.1002/1097-0142(19930715)72:2
Cited by
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study
Hurria, A., Togawa, K., Mohile, S. G., Owusu, C., Klepin, H. D., Gross, C. P., Lichtman, S. M., Gajra, A., Bhatia, S., Katheria, V., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.7625 · Cited by 1,841
ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer
Locker, G. Y., Hamilton, S., Harris, J., Jessup, J. M., Kemeny, N., Macdonald, J. S., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2644 · Cited by 1,592
Self-citationAdjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study
QUASAR Collaborative Group (2007) · The Lancet · doi:10.1016/s0140-6736(07)61866-2 · Cited by 1,437
Benson, A. B., Schrag, D., Somerfield, M. R., Cohen, A. M., Figueredo, A. T., Flynn, P. J., Krzyzanowska, M. K., Maroun, J., McAllister, P., Van Cutsem, E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.063 · Cited by 1,430
Self-citationSystemic Therapy for Colorectal Cancer
Meyerhardt, J. A., & Mayer, R. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra040958 · Cited by 1,043
Metadata
- Authors
- Sargent, D. J., Goldberg, R. M., Jacobson, S. D., Macdonald, J. S., Labianca, R., Haller, D. G., Shepherd, L. E., Seitz, J. F., & Francini, G.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2001-10-11
- Volume
- 345
- Issue
- 15
- Pages
- 1091-1097
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2017654486
- Cited by
- 986
- References
- 47
- FWCI
- 15.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.